Remdesivir Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04694612Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal